https://doi.org/10.4081/hmr.v1i8.274

ICL670: clinical outcome

Vol. 1 No. 8: New Drugs in Hematology, Bologna, October 9-11, 2005
Published: May 29, 2009
Abstract Views: 140
PDF: 300
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

MD Cappellini
support@pagepress.org
In thalassemia, myelodysplastic syndrome (MDS) and sickle cell disease (SCD), long-term substitution therapy for anemia results in toxic iron overload which constitutes a significant medical problem. As humans have no physiological mechanism to excrete excess iron, this is deposited in the form of ferritin and hemosiderin in the liver, spleen, many endocrine organs and in the myocardium. This accumulation results in a host of clinical complications such as heart disease, diabetes, hypothyroidism and liver failure, and the primary causes of death among patients who require regular transfusions are due to the effects of iron overload rather than the underlying problem.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Cappellini, M. (2009). ICL670: clinical outcome. Hematology Meeting Reports (formerly Haematologica Reports), 1(8). https://doi.org/10.4081/hmr.v1i8.274
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).